Affiliations 

  • 1 PAPRSB Institute of Health Sciences, Universiti Brunei Darussalam, Brunei Darussalam
  • 2 National Cancer Center Institute for Cancer Control, Tokyo, Japan
  • 3 Health Promotion Board, Singapore
  • 4 Bureau of International Health Cooperation, National Center for Global Health and Medicine, Japan
  • 5 Pandit Madan Mohan Malviya Cancer Centre & Homi Bhabha Cancer Hospital, Tata Memorial Centre, Varanasi, India
  • 6 Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia
  • 7 Department of Radiation Oncology, Dr B R Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, Delhi, India
  • 8 Department of Gynaecological Oncology, Bangabandhu Sheikh Mujib Medical University, Bangladesh
  • 9 Cancer Registry-surveillance and Early Detection Division, National Cancer Center of Mongolia, Ulaanbaatar, Mongolia
  • 10 National Cancer Center Indonesia, Dharmais Cancer Hospital, Jakarta, Indonesia
  • 11 Research Institute for Oncology, Hematology and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran
  • 12 Shaukat Khanum Memorial Cancer Hospital and Research Centres, Lahore and Peshawar, Pakistan
  • 13 Jigme Dorji Wangchuck National Referral Hospital, Bhutan
  • 14 National Cancer Control Programme, Ministry of Health, Sri Lanka
  • 15 Department of Health, Disease Prevention and Control Bureau, Manila, Philippines
  • 16 Department of Public Health, Ministry of Health, Naypyidaw, Myanmar
  • 17 Calmette Hospital, Phnom Penh, Cambodia
  • 18 Cancer Center, Mittaphab Hospital, Vientiane, Lao PDR
  • 19 Kathmandu Cancer Center Hospital, Tathali, Bhaktapur, Nepal
  • 20 National Cancer Center Korea, Goyang, Republic of Korea
  • 21 Vietnam National Cancer Institute & Hanoi Medical University, Hanoi, Vietnam
  • 22 National Cancer Institute, Bangkok, Thailand
  • 23 National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
  • 24 International Agency for Research on Cancer (IARC/WHO), Lyon, France
  • 25 University of Malaya & ROSE Foundation, Kuala Lumpur, Malaysia
  • 26 The Brunei Cancer Center, PJSC, Brunei Darussalam
  • 27 National Cancer Centre & Duke-NUS Medical School, Singapore
Lancet Reg Health West Pac, 2023 Oct;39:100860.
PMID: 37576906 DOI: 10.1016/j.lanwpc.2023.100860

Abstract

About 95% of cervical cancers worldwide are caused by human papillomavirus (HPV). Cervical cancer is preventable and curable if it is detected and treated early. We reviewed the latest national cervical cancer indicators, and barriers to HPV vaccination and cervical cancer screening in 21 Asian National Cancer Centers Alliance (ANCCA) member countries. Half (n = 11, 52%) of the countries have introduced HPV vaccination for girls as part of their national vaccination programme, three countries reported coverage of over 90%. Most ANCCA member countries have cervical cancer screening programmes, only five countries reported screening uptake of over 50%. The barriers to HPV vaccination coverage and cervical cancer screening participation have been identified. Ensuring health service accessibility and affordability for women, addressing sociocultural barriers, and strengthening the healthcare system and continuum of care are essential to increase HPV vaccination and cervical cancer screening coverage.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications